Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions Hossein Haji Ali AfzaliJonathan Karnon Editorial 23 September 2012 Pages: 823 - 825
Cautions Regarding the Fitting and Interpretation of Survival Curves Martin ConnockChris HydeDavid Moore Practical Application 23 September 2012 Pages: 827 - 837
A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease Joseph MenzinLisa M. LinesTracy Mayne Review Article 23 September 2012 Pages: 839 - 861
Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer Gery P. Guy JrDonatus U. Ekwueme Review Article 23 September 2012 Pages: 863 - 874
Does the Market Share of Generic Medicines Influence the Price Level? Pieter DylstSteven Simoens Original Research Article 23 September 2012 Pages: 875 - 882
Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs Alain DenisLut MergaertSteven Simoens Original Research Article 23 September 2012 Pages: 883 - 893
Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium Mickaƫl HiligsmannJean-Yves Reginster Original Research Article 23 September 2012 Pages: 895 - 911